Double Medical Technology Inc
SZSE:002901

Watchlist Manager
Double Medical Technology Inc Logo
Double Medical Technology Inc
SZSE:002901
Watchlist
Price: 34.4 CNY Market Closed
Market Cap: 14.2B CNY
Have any thoughts about
Double Medical Technology Inc?
Write Note

Double Medical Technology Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Double Medical Technology Inc
Research & Development Peer Comparison

Comparables:
A
688617
J
002223
300760
J
300529
688271

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Double Medical Technology Inc
SZSE:002901
Research & Development
-ÂĄ295.5m
CAGR 3-Years
-29%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Research & Development
-ÂĄ219.1m
CAGR 3-Years
-48%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Research & Development
-ÂĄ500.3m
CAGR 3-Years
-7%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Research & Development
-ÂĄ3.4B
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Research & Development
-ÂĄ243.5m
CAGR 3-Years
-34%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Research & Development
-ÂĄ1.7B
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Double Medical Technology Inc's Research & Development?
Research & Development
-295.5m CNY

Based on the financial report for Jun 30, 2024, Double Medical Technology Inc's Research & Development amounts to -295.5m CNY.

What is Double Medical Technology Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-31%

Over the last year, the Research & Development growth was -6%. The average annual Research & Development growth rates for Double Medical Technology Inc have been -29% over the past three years , -31% over the past five years .

Back to Top